180 Life Sciences Corp (NASDAQ:ATNF) does about 1.49M shares in volume on a normal day but saw 17020777 shares change hands in the recent trading day. The company now has a market cap of 2.67M USD. Its current market price is $5.03, marking an increase of 16.17% compared to the previous close of $4.33. The 52 week high reached by this stock is $17.75 whilst the lowest price level in 52 weeks is $1.16.
180 Life Sciences Corp (ATNF) has a 20-day trading average at $2.09 and the current price is -71.66% off the 52-week high compared with 333.62% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.98 and its 200-day simple moving average is $2.45. If we look at the stock’s price movements over the week, volatility stands at 62.30%, which decreases to 22.92% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 68.18 to suggest the stock is neutral.
The consensus objective for the share price is $1520.00, suggesting that the stock has a potential upside of 99.67% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on September 15, 2021 when Maxim Group initiated the stock to “Buy” and issued a price target of $11.
The current price level is 141.02%, 154.31%, and 105.52% away from its SMA20, SMA50, and SMA200 respectively, with the ATNF price moving below the 50-day SMA on current market day. 180 Life Sciences Corp (ATNF) stock is up 281.06% over the week and 161.98% over the past month. Its price is 24.00% year-to-date and -48.09% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/30/2022, with the company’s earnings per share (EPS) of 19 above consensus estimates by 68.4. The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 99.67 percent from here.
Outstanding shares total 0.53M with insiders holding 1.49% of the shares and institutional holders owning 6.39% of the company’s common stock. The company has a return on equity of -398.58%.
